Cargando…
Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer
PURPOSE: Prescribing NAC for breast cancer is a pragmatic treatment strategy for several reasons; however, certain patients suffer chemotherapy-induced toxicities. Unfortunately, identifying patients at risk of toxicity often proves challenging. MiRNAs are small non-coding RNA molecules which modula...
Autores principales: | Davey, Matthew G., Abbas, Ray, Kerin, Eoin P., Casey, Maire Caitlin, McGuire, Andrew, Waldron, Ronan M., Heneghan, Helen M., Newell, John, McDermott, Ailbhe M., Keane, Maccon M., Lowery, Aoife J., Miller, Nicola, Kerin, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504160/ https://www.ncbi.nlm.nih.gov/pubmed/37540289 http://dx.doi.org/10.1007/s10549-023-07033-8 |
Ejemplares similares
-
Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer: A Prospective, Multicenter Clinical Trial
por: Davey, Matthew G., et al.
Publicado: (2022) -
Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial
por: Davey, Matthew G, et al.
Publicado: (2022) -
Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
por: McGuire, Andrew, et al.
Publicado: (2020) -
Relationship between Circulating and Tissue microRNAs in a Murine Model of Breast Cancer
por: Waters, Peadar S., et al.
Publicado: (2012) -
Identification and Validation of miRNAs as Endogenous Controls for RQ-PCR in Blood Specimens for Breast Cancer Studies
por: McDermott, Ailbhe M., et al.
Publicado: (2013)